AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16671073 — intervention group
Group type: COMPARATOR
Intervention: Medication
Number of subjects: 28
Study 16671073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus deep brain stimulation (B‐STN DBS) plus medication
Number of subjects: 28
Study 14557884 — intervention group
Group type: EXPERIMENTAL
Intervention: Judo wrestling
Number of subjects: 10
Study 14557884 — intervention group
Group type: COMPARATOR
Intervention: Cycloergometric exercise
Number of subjects: 10
Study 14557884 — intervention group
Group type: COMPARATOR
Intervention: Judo wrestling and Cycloergometric exercise
Number of subjects: 10
Study 11739970 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 levels
Number of subjects: 39
Study 11739970 — intervention group
Group type: EXPERIMENTAL
Intervention: HT presence
Number of subjects: 39
Study 9272101 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH at a weekly dosage of 0.5 IU/kg
Number of subjects: 362
Study 9272101 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH at a weekly dosage of 1.0 IU/kg
Number of subjects: 362
Study 9272101 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 362
Study 8430283 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam Liner
Number of subjects: 29
Study 8430283 — intervention group
Group type: EXPERIMENTAL
Intervention: Copalite
Number of subjects: 29
Study 8430283 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 29
Study 8430283 — intervention group
Group type: COMPARATOR
Intervention: All groups (Amalgam Liner, Copalite, Untreated)
Number of subjects: 29
Study 3894693 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (2,000 rad)
Number of subjects: 92
Study 3894693 — intervention group
Group type: COMPARATOR
Intervention: Radical cystectomy alone
Number of subjects: 92
Study 31802059 — intervention group
Group type: EXPERIMENTAL
Intervention: EVOO therapy
Number of subjects: 108
Study 31802059 — intervention group
Group type: COMPARATOR
Intervention: Control group (MCI without therapy)
Number of subjects: 108
Study 29624536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (n = 19)
Number of subjects: 43
Study 29624536 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n = 24)
Number of subjects: 43
Study 27101729 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublobar resection alone
Number of subjects: 212
Study 27101729 — intervention group
Group type: COMPARATOR
Intervention: Sublobar resection with brachytherapy
Number of subjects: 212
Study 24401516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabs'Air Composite (Cousin Biotech France)
Number of subjects: 83
Study 24401516 — intervention group
Group type: COMPARATOR
Intervention: Ventralex Hernia Patch (Bard USA)
Number of subjects: 83
Study 22157510 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized isopropanolic black cohosh extract (Remifemin)
Number of subjects: 304
Study 22157510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 20846724 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof Toric IOL
Number of subjects: 517
Study 20846724 — intervention group
Group type: COMPARATOR
Intervention: AcrySof spherical control IOL
Number of subjects: 517
Study 17469691 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 16173887 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS education intervention
Number of subjects: 0
Study 16173887 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (control)
Number of subjects: 0
Study 16173887 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up scores
Number of subjects: 0
Study 12231575 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA diet + simvastatin (20 mg daily)
Number of subjects: 63
Study 12231575 — intervention group
Group type: COMPARATOR
Intervention: AHA diet + placebo
Number of subjects: 63
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR improvement criteria
Number of subjects: 9
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: EULAR improvement criteria
Number of subjects: 9
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR and EULAR with extensive joint counts
Number of subjects: 9
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR and EULAR with reduced joint counts
Number of subjects: 9
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall assessment of improvement by investigator and patient
Number of subjects: 9
Study 10090187 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic progression association
Number of subjects: 9
Study 7581096 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF 250 micrograms/m2/day
Number of subjects: 109
Study 7581096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 1710162 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 40
Study 1710162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6893787 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose hydrolyzed milk
Number of subjects: 14
Study 6893787 — intervention group
Group type: COMPARATOR
Intervention: Nonhydrolyzed milks
Number of subjects: 14
Study 6893787 — intervention group
Group type: COMPARATOR
Intervention: Taste panel assessment
Number of subjects: 14
Study 31418121 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g rice with 4 g dried wakame
Number of subjects: 26
Study 31418121 — intervention group
Group type: COMPARATOR
Intervention: 200 g rice
Number of subjects: 26
Study 28317321 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered training group
Number of subjects: 20
Study 28317321 — intervention group
Group type: COMPARATOR
Intervention: Unfiltered training group
Number of subjects: 20
Study 28317321 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 25145870 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention followed by self-regulatory intervention
Number of subjects: 205
Study 25145870 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory intervention followed by motivational intervention
Number of subjects: 205
Study 25145870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (received by all participants by Time 3)
Number of subjects: 205
Study 24189173 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Sexual Risk Management (BSRM)
Number of subjects: 30
Study 24189173 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Sexual Risk Management (ESRM)
Number of subjects: 30
Study 21329988 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20mg/day plus celecoxib 400mg/day (200mg BID)
Number of subjects: 50
Study 21329988 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20mg/day plus placebo
Number of subjects: 50
Study 18789466 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Giardia and anthelminthic treatment
Number of subjects: 222
Study 18789466 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Giardia treatment only
Number of subjects: 222
Study 18789466 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 222
Study 17721622 — intervention group
Group type: EXPERIMENTAL
Intervention: tinzaparin at 175 IU/kg, subcutaneous once daily, along with supportive care including morphine analgesia
Number of subjects: 253
Study 17721622 — intervention group
Group type: COMPARATOR
Intervention: placebo and the same supportive care
Number of subjects: 253
Study 15487811 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisolone (test) tablets
Number of subjects: 18
Study 15487811 — intervention group
Group type: COMPARATOR
Intervention: Delta‐Cortef (reference) tablets
Number of subjects: 18
Study 11451307 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral pull test
Number of subjects: 107
Study 11451307 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tilt test
Number of subjects: 107
Study 9569193 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (mean: 10 kg)
Number of subjects: 98
Study 9569193 — intervention group
Group type: COMPARATOR
Intervention: Heterozygotes (Arg/Gln353)
Number of subjects: 98
Study 9569193 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype (Arg353 homozygotes vs. heterozygotes)
Number of subjects: 98
Study 9569193 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (6 months)
Number of subjects: 98
Study 9569193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional and longitudinal associations
Number of subjects: 98
Study 7923797 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose transdermal estrogen (Estraderm TTS 25 micrograms) + oral progestogen (Duphaston 10 mg, 10 days every month) + daily exercise (walking for 1 hour)
Number of subjects: 33
Study 7923797 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal from HRT after 6 months
Number of subjects: 33
Study 3062225 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg molsidomine
Number of subjects: 37
Study 3062225 — intervention group
Group type: COMPARATOR
Intervention: 10 mg isosorbide dinitrate
Number of subjects: 37
Study 31561399 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill-induced slips (12m/s²) followed by a novel trip (16.8m/s²)
Number of subjects: 26
Study 31561399 — intervention group
Group type: COMPARATOR
Intervention: Control group (single unannounced trip)
Number of subjects: 26
Study 27453154 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized manometric biofeedback protocol
Number of subjects: 24
Study 27453154 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and certification of interventionists
Number of subjects: 24
Study 27453154 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback software on a novel tablet computer platform
Number of subjects: 24
Study 26147154 — intervention group
Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (25 mg/150 mg/100 mg) for 12 weeks (group A)
Number of subjects: 363
Study 26147154 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 363
Study 26147154 — intervention group
Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (group C)
Number of subjects: 363
Study 26147154 — intervention group
Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (overall)
Number of subjects: 363
Study 23386268 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement of dietary saturated fats with omega 6 linoleic acid
Number of subjects: 458
Study 23386268 — intervention group
Group type: COMPARATOR
Intervention: Updated meta-analysis of linoleic acid intervention trials
Number of subjects: 458
Study 21040436 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium for 3 days (Group B)
Number of subjects: 66
Study 21040436 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium for 7 days (Group C)
Number of subjects: 66
Study 21040436 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days (Group A)
Number of subjects: 66
Study 18176329 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor (PI)
Number of subjects: 1301
Study 18176329 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Number of subjects: 1301
Study 18176329 — intervention group
Group type: EXPERIMENTAL
Intervention: PI plus NNRTI-based combinations
Number of subjects: 1301
Study 16633779 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (D)
Number of subjects: 50
Study 16633779 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (P)
Number of subjects: 50
Study 12809957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 5 mg TID
Number of subjects: 1405
Study 12809957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 10 mg TID
Number of subjects: 1405
Study 12809957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 2.5 mg TID
Number of subjects: 1405
Study 12809957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1405
Study 10768448 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with progenitor-cell rescue
Number of subjects: 0
Study 10768448 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose chemotherapy
Number of subjects: 0
Study 9275441 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback pulsatile oxytocin system
Number of subjects: 224
Study 9275441 — intervention group
Group type: COMPARATOR
Intervention: Continuous intravenous infusion of oxytocin (control group)
Number of subjects: 224
Study 1511813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flow oxygen (2 liters/min) via nasal prongs or nasopharyngeal cannula
Number of subjects: 50
Study 1511813 — intervention group
Group type: COMPARATOR
Intervention: No oxygen
Number of subjects: 50
Study 6378245 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted and undiluted topical corticosteroid preparations
Number of subjects: 0
Study 6378245 — intervention group
Group type: COMPARATOR
Intervention: Vasoconstrictor assay
Number of subjects: 0
Study 30209672 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based training using educational videos and manikins; teachers trained with a BLS/AED course.
Number of subjects: 5146
Study 28944356 — intervention group
Group type: EXPERIMENTAL
Intervention: Machined implants
Number of subjects: 40
Study 28944356 — intervention group
Group type: COMPARATOR
Intervention: Roughened implants
Number of subjects: 40
Study 28944356 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 25823480 — intervention group
Group type: EXPERIMENTAL
Intervention: Papacarie®
Number of subjects: 25
Study 25823480 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling method
Number of subjects: 25
Study 24318688 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia training (HT, FiO2=16.4-14.5%)
Number of subjects: 22
Study 24318688 — intervention group
Group type: COMPARATOR
Intervention: Normoxia training (NT, FiO2=21%)
Number of subjects: 22
Study 24318688 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia training (HT)
Number of subjects: 22
Study 24318688 — intervention group
Group type: COMPARATOR
Intervention: Normoxia training (NT)
Number of subjects: 22
Study 21904901 — intervention group
Group type: EXPERIMENTAL
Intervention: lamotrigine (target dose 400 mg/day)
Number of subjects: 117
Study 21904901 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 117
Study 20846382 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid accumulation product (LAP)
Number of subjects: 6751
Study 20846382 — intervention group
Group type: COMPARATOR
Intervention: Waist-to-hip-ratio (WHpR)
Number of subjects: 6751
Study 17440020 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofluorophosphate (MFP) 20 mg/d
Number of subjects: 80
Study 17440020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 14988822 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (NMDA receptor antagonist)
Number of subjects: 32
Study 14988822 — intervention group
Group type: COMPARATOR
Intervention: Saline (vehicle)
Number of subjects: 32
Study 11589718 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop diuretic (LD; bumetanide)
Number of subjects: 50
Study 11589718 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide diuretic (TD; bendroflumethiazide)
Number of subjects: 50
Study 11589718 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop diuretic plus Thiazide diuretic (LD plus TD)
Number of subjects: 50
Study 11589718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9716148 — intervention group
Group type: EXPERIMENTAL
Intervention: dilute Russell's Viper Venom Time (dRVVT)
Number of subjects: 10
Study 9716148 — intervention group
Group type: EXPERIMENTAL
Intervention: dilute Kaolin Clotting Time (dKCT)
Number of subjects: 10
Study 9716148 — intervention group
Group type: EXPERIMENTAL
Intervention: polyacrylamide‐immobilised phosphatidylserine column
Number of subjects: 10
Study 9716148 — intervention group
Group type: COMPARATOR
Intervention: phospholipid liposomes
Number of subjects: 10
Study 9716148 — intervention group
Group type: EXPERIMENTAL
Intervention: routine detection of LA antibodies
Number of subjects: 10
Study 7983959 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (n = 114)
Number of subjects: 233
Study 7983959 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 119)
Number of subjects: 233
Study 2574892 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective Deficit Syndrome Scale (SDSS) assessment
Number of subjects: 0
Study 2574892 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 970902 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide prophylaxis (20-60 mg) in LPG
Number of subjects: 45
Study 970902 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide prophylaxis in SPG
Number of subjects: 45
Study 970902 — intervention group
Group type: COMPARATOR
Intervention: Control group (no furosemide prophylaxis)
Number of subjects: 45
Study 30070753 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly
Number of subjects: 0
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 25‐<30 kg/m2
Number of subjects: 25554
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 30 kg/m2
Number of subjects: 25554
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: Each unit increase in baseline BMI
Number of subjects: 25554
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes
Number of subjects: 25554
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes during ≤ 2 years' follow-up
Number of subjects: 25554
Study 28326193 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline history of diabetes during > 2 years' follow-up
Number of subjects: 25554
Study 25594519 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task net-step exercise (NSE) performed once a week for 8 consecutive weeks
Number of subjects: 60
Study 25594519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 23458849 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive online intervention
Number of subjects: 189
Study 23458849 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 189
Study 21388938 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc 300 mg twice daily
Number of subjects: 721
Study 21388938 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz 600 mg once daily
Number of subjects: 721
Study 19283947 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD‐based, peer delivered intervention
Number of subjects: 343
Study 19283947 — intervention group
Group type: COMPARATOR
Intervention: NIDA Standard HIV Intervention
Number of subjects: 343
Study 19283947 — intervention group
Group type: COMPARATOR
Intervention: Standard practice condition (HIV educational video)
Number of subjects: 343
Study 16579711 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 20
Study 16579711 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaler
Number of subjects: 20
Study 12620955 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 200
Study 12620955 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone
Number of subjects: 200
Study 12620955 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chromoglycate
Number of subjects: 200
Study 12620955 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study 11090872 — intervention group
Group type: EXPERIMENTAL
Intervention: MND Association Survey and ALSAQ‐40 questionnaire
Number of subjects: 500
Study 11090872 — intervention group
Group type: COMPARATOR
Intervention: MND Association Survey
Number of subjects: 500
Study 9198716 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil cationic protein (ECP) concentration in blood serum
Number of subjects: 53
Study 9198716 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive results of prick test
Number of subjects: 53
Study 9198716 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased total IgE concentration
Number of subjects: 53
Study 8464952 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DMI
Number of subjects: 24
Study 8464952 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DMI
Number of subjects: 24
Study 8464952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3511767 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine 0.3 mg
Number of subjects: 0
Study 3511767 — intervention group
Group type: COMPARATOR
Intervention: Epidural morphine 4 mg
Number of subjects: 0
Study 31385000 — intervention group
Group type: EXPERIMENTAL
Intervention: TKA with tourniquet
Number of subjects: 20
Study 31385000 — intervention group
Group type: COMPARATOR
Intervention: TKA without tourniquet
Number of subjects: 20
Study 29255930 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 400 µg/day
Number of subjects: 180
Study 29255930 — intervention group
Group type: COMPARATOR
Intervention: Convention (control group)
Number of subjects: 180
Study 28770664 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy plus standard care (12 weeks)
Number of subjects: 70
Study 28770664 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 70
Study 27060461 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 55
Study 25292137 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH for 2 days during the perioperative period
Number of subjects: 93
Study 25292137 — intervention group
Group type: COMPARATOR
Intervention: LMWH for 7 days during the perioperative period
Number of subjects: 93
Study 25292137 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer > 0.987 mcg/ml and swelling > 1.5 cm of shin
Number of subjects: 93
Study 22378727 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol (PS) supplementation (1.6 g daily for 4 weeks)
Number of subjects: 25
Study 19597773 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking compression plating
Number of subjects: 120
Study 19597773 — intervention group
Group type: COMPARATOR
Intervention: Dorsal plating
Number of subjects: 120